Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults
NCT: NCT04710615 · TERMINATED
Brief Summary
Polypharmacy in the older adults is common and promotes the risk of drug interactions. The hypothesis evoked is that a virtual platform with artificial intelligence applied to the health, and in particular to the good use of the drug, could bring aids to the doctors them of the prescription of drugs. The main objective of this study is to evaluate the impact of geriatric use of the Synapse platform on the frequency of inappropriate medication prescriptions (STOPP criteria) in discharge orders for patients 65 years of age or older hospitalized in geriatric department.
Frequently Asked Questions
What is Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults?
Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults is a clinical trial registered under NCT04710615. Current status: TERMINATED.
What is the status of NCT04710615?
The current status of NCT04710615 (Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults) is: TERMINATED.
When did Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults start?
Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults started on 2021-10-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.